Close Message
None

Quotes

  1. We are also excited about the potential of our CardioSpectra acquisition and its Optical Coherence Tomography (OCT) technology as a complement to our IVUS offerings. Our product development program for this technology is on track and we hope to have our first offering in this area available for launch in the United States and Europe next year.
    By Scott Huennekens

Entities Mentioned


HomeAll ArticlesProfilesQuotesComments Login Register Powered by HiveFire